Orthopedics CME

Credits: 0.50 CME / CPE
Purdue University
A Biosimilars Primer for Managed Care
Stanley Cohen, MD
6 October, 2017
Credits: 0.50 CME
Medical Learning Institute, Inc.
Systemic Juvenile Idiopathic Arthritis: Overcoming Challenges in Diagnosis and Management to Individualize Care and Achieve Treatment Goals
Timothy Beukelman, MD, MSCE
27 September, 2017
Credits: 0.50 CME
Medical Learning Institute, Inc.
JAK Inhibitors in Rheumatoid Arthritis: Aligning Pathophysiology, Treatment Advances, and Patient Preference Into a Personalized Approach to Care for Improved Outcomes
William Rigby, MD
26 September, 2017
Credits: 0.50 CME
Medical Learning Institute, Inc.
Navigating the Diagnosis and Treatment of Ankylosing Spondylitis: Strategies to Improve Outcomes and Enhance Patient Quality of Life
Atul Deodhar, MD
25 September, 2017
Credits: 0.50 CME
Medical Learning Institute, Inc.
Addressing Unmet Needs in Rheumatoid Arthritis Through Novel Treatment Options and Enhanced Physician–Patient Collaboration
Alan Kivitz, MD, CPI
25 August, 2017
Credits: 0.50 CME
Medical Learning Institute, Inc.
Optimizing Outcomes Throughout the Journey of Patients With Psoriatic Arthritis: A Closer Look at the Importance of Early Diagnosis and Role of New Treatment Options
Philip Mease, MD, MACR
25 July, 2017
Credits: 0.50 CME
Medical Learning Institute, Inc.
Emerging Therapeutic Strategies in RA: A Closer Look at the Role of JAK Inhibition
William Rigby, MD
31 May, 2017
Credits: 0.75 CME
University of Cincinnati
Improving Outcomes in Patients With Uveitis: Strengthening the Connection Between Ophthalmologists and Rheumatologists in an Era of New Treatment Options
Glenn Jaffe, MD
25 May, 2017
Credits: 0.50 CME
Medical Learning Institute, Inc.
Biosimilars in Rheumatoid Arthritis: What Does a Changing Treatment Landscape Mean for You and Your Patients?
Leonard Calabrese, DO
5 May, 2017